Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “ELECTRODES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 235 records · Page 13Linked to original sources
PubMed1981

Clinical evaluation of an automatic potassium electrode. Use of the Nova 1 ion-selective electrode in a cardiac surgical intensive care unit.

A Nova 1 potassium analyser has been evaluated for the first 3 months of its use in a cardiac surgical intensive care unit. The machine was out of action for 11 out of 104 days. 515 external calibrations were performed with 4.50 mmol/l potassium standards: mean 4.49 mmol/l, standard deviation 0.07. 692 comparisons were made with routine laboratory flame photometer measurements on the same sample: correlation coefficient r = 0.815. It is concluded that Nova 1, if kept in working order, can provide potassium estimations quickly and accurately.

Cardiac Surgical Procedures↗
PubMed1993

A randomized comparison of a bipolar steroid-eluting electrode and a bipolar microporous platinum electrode: implications for long-term programming.

Differences in acute and chronic pacing thresholds were compared in patients receiving either the Medtronic Model 4004 steroid-eluting lead or the Medtronic Model 4012 microporous platinum lead. Patients (n = 35) were randomized at the time of implant to receive either a steroid-eluting (n = 17) or a microporous (n = 18) lead. Pacing thresholds were determined within 24 hours and at 2, 4, 6, 12, 24, and 52 weeks postimplant. By 2 weeks postimplant, pacing thresholds measured at 0.8, 1.6, 2.5, 3.3, and 4.2 V were significantly lower in the steroid lead group compared to the microporous lead group (P < 0.05). At 24 weeks, the voltage threshold at 0.3 msec was 0.8 V in 88% of patients with a steroid lead whereas this threshold was only observed in 33% of patients with the microporous lead (P < 0.01). At 52 weeks the pacing energy measured at 1.6 V, twice pulse duration threshold, was significantly lower in the steroid lead group (0.81 +/- 0.59 microJ) compared to the microporous lead group (1.25 +/- 0.60 microJ, P < 0.05). Thirteen patients in the steroid lead group and 9 patients in the microporous lead group have been programmed at a pulse amplitude of 1.6 V since the 24-week follow-up visit. These patients have been followed for a minimum of 6 months without documented failure to capture. This study shows that pacemaker/lead systems with stable chronic low thresholds can be safely programmed to low pulse amplitude settings. This practice will prolong the longevity of pulse generators.

Aged↗